Radiopharmaceuticals (2nd Ed., 2nd ed. 2020) A Guide to PET/CT and PET/MRI
Coordonnateurs : Calabria Ferdinando, Schillaci Orazio
The book reflects the rapid development of several PET tracers over the last decade, as a result of which the ?traditional? PET/CT with 18F-FDG, the ?cornerstone? of PET imaging, is now only one of several available options, which use different tracers for different diseases. For the same reason, PET imaging is no longer limited to the field of oncology.
In the editors? experience, students in medicine and residents in nuclear medicine and radiology have limited access to scientific papers concerning novel PET tracers. Moreover, these papers generally focus on a single PET radiopharmaceutical. With approx. 20 radiopharmaceuticals explained in detail and a wealth of images and clinical cases, the book represents a versatile, comprehensive and practice-oriented guide to PET imaging, pursuing a unique and novel approach to the clinical role of PET tracers.
The book?s didactic nature also makes it an invaluable tool for residents in nuclear medicine and radiology, as well as for radiographers and clinicians in radiotherapy, oncology, hematology, cardiology and neurology.
Prof. Orazio Schillaci graduated with a degree in Medicine in 1990 and specialized in Nuclear Medicine in 19942 at the University of Rome “La Sapienza.” He began his scientific work at the University of L’Aquila: during this important period, Schillaci started exploring molecular imaging, with an emphasis on SPECT for neuroendocrine tumors. After a research stay in California, USA, he became a Professor of Nuclear Medicine at the University of Rome “Tor Vergata” in 2001. Since 2008 he
Highlights the crucial role of novel PET radiopharmaceuticals in the clinical usefulness of PET
Features approx. 20 radiopharmaceuticals and their role in clinics
PET/CT acquisition protocols, specific to each tracer, are presented in each chapter
Provides over 50 multi-imaging figures (contrast enhanced CT and/or PET/CT and/or SPECT and/or PET/MRI and/or MRI)
Presents numerous clinical cases, with multi-tracer evaluation in a single patient, revealing mismatches or diagnostic overlap
Date de parution : 10-2020
Ouvrage de 234 p.
17.8x25.4 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 89,66 €
Ajouter au panierThèmes de Radiopharmaceuticals :
Mots-clés :
PET/CT; PET/MRI; Atlas; Guide; tracers; molecular imaging; theranostics; Radiaton Oncology